- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
CPhI Worldwide Entries for 15th Annual Pharma Awards Now Open
CPhI Worldwide-organized by UBM (part of Informa PLC)-announced the award entries for the 2018 CPhI Pharma Awards. The industry’s awards return for a 15th edition, with 17 categories honoring companies and individuals driving the pharma industry forward through innovations, technologies, and strategies.
Categories include innovations across APIs, excipients, and formulations to drug delivery technologies, packaging, patient-centricity, contract services, and business performance focused awards.
This year the Bioprocessing & Manufacturing category-powered by the new bioLIVE event-is expected to see an increase in applications in light of the increased biologics and supply chain audiences now attending CPhI Worldwide. Among 2017’s most hotly contested categories were API Development, along with the fiercely competitive ‘Product Packaging’ and ‘Drug Delivery and Devices’ categories. Another increasingly significant category is the Corporate Social Responsibility award.
Submitting your entry(ies) for the CPhI Pharma Awards is free of charge and the deadline is July 31st 2018-with shortlisted finalists announced August 28th, 2018. The winners will be unveiled during a ceremony at the Eurostars Madrid Tower in Madrid, on October 9th during the evening of the first day of CPhI Worldwide.
To apply please visit https://awards.cphi.com
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
What Every Pharma CEO Should Know About Unlocking Scientific Data Potential
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
